Published in Am J Med on October 01, 1986
Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis (1993) 1.14
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg (2003) 3.32
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61
Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia (2007) 2.52
Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up. Diabetes Care (2001) 2.45
Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ (1997) 2.33
The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol (2001) 2.27
Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol (1988) 2.25
Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia (2002) 2.23
Prevalence and etiology of asthma. J Allergy Clin Immunol (2000) 2.19
Passive smoking and passive thinking. N Z Med J (1989) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry (2007) 2.03
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Does environmental endotoxin exposure prevent asthma? Thorax (2002) 1.88
Defining asthma in epidemiological studies. Eur Respir J (1999) 1.88
Occupational asthma in New Zealanders: a population based study. Occup Environ Med (1997) 1.84
Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy (2007) 1.81
The ecological fallacy strikes back. J Epidemiol Community Health (2000) 1.79
Latency analysis in occupational epidemiology. Arch Environ Health (1990) 1.77
Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia (1996) 1.70
Epidemiology: bridges over (and across) roaring levels. J Epidemiol Community Health (1998) 1.69
Socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Respir J (2007) 1.64
Pancreatitis and the risk of pancreatic cancer. Pancreas (1995) 1.64
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Poverty, health services, and health status in rural America. Milbank Q (1988) 1.61
Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med (2004) 1.60
Prevalence and risk factors for self-reported asthma in an adult Indian population: a cross-sectional survey. Int J Tuberc Lung Dis (2013) 1.57
The self reported prevalence of asthma symptoms amongst adult New Zealanders. N Z Med J (1994) 1.57
Risk factors for asthma symptoms in Kawerau children. N Z Med J (1994) 1.56
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy (2009) 1.55
Asthma in Maori people. N Z Med J (1992) 1.54
Screening and prevention of diabetic blindness. Acta Ophthalmol Scand (2000) 1.51
Ethics of ignorance: lessons from the epidemiological assessment of the bovine spongioform encephalopathy ("mad cow disease") epidemic. Perspect Biol Med (1998) 1.51
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Success and failure at inpatient heroin detoxification. Br J Addict (1989) 1.48
Environmental epidemiology: challenges and opportunities. Environ Health Perspect (2001) 1.47
Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J (2001) 1.46
Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer (1989) 1.43
Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy (1999) 1.43
Trends in asthma mortality in New Zealand, 1908-1986. Med J Aust (1990) 1.41
Modes of hepatitis B virus transmission in New Zealand. N Z Med J (1989) 1.39
Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Thorax (1997) 1.39
Fenoterol and asthma death. N Z Med J (1989) 1.39
Asthma deaths in New Zealand. BMJ (1992) 1.38
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care (2001) 1.38
Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health (1998) 1.38
Impact of changes in the death registration process upon Maori mortality statistics. N Z Med J (1999) 1.38
Fenoterol: confounding again. N Z Med J (1989) 1.38
Inappropriate use of inhaled beta agonists in asthma. N Z Med J (1990) 1.37
Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet (1982) 1.35
Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect (1998) 1.32
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol (2009) 1.30
A simple computer program for generating person-time data in cohort studies involving time-related factors. Am J Epidemiol (1987) 1.27
Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract (2006) 1.26
Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer (1994) 1.25
Measuring the prevalence of bronchial hyper-responsiveness in children. Int J Epidemiol (1995) 1.24
Relationship between fetal growth and the development of asthma and atopy in childhood. Thorax (1999) 1.23
Comparison of a video questionnaire with the IUATLD written questionnaire for measuring asthma prevalence. Clin Exp Allergy (1992) 1.23
Chronic bronchitis, work related respiratory symptoms, and pulmonary function in welders in New Zealand. Occup Environ Med (1998) 1.19
Two year follow up of pulmonary function values among welders in New Zealand. Occup Environ Med (1999) 1.18
Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol (1999) 1.18
Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol (2008) 1.16
A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care (2000) 1.15
Social class inequalities in the decline of coronary heart disease among New Zealand men, 1975-1977 to 1985-1987. Int J Epidemiol (1991) 1.15
Adult-onset acute leukemia and employment in the meat industry: a New Zealand case-control study. Cancer Causes Control (2001) 1.15
Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol (1992) 1.13
Asthma prevalence and deprivation: a small area analysis. J Epidemiol Community Health (1999) 1.13
Lifelong farm exposure may strongly reduce the risk of asthma in adults. Allergy (2007) 1.12
Farm exposure in utero may protect against asthma, hay fever and eczema. Eur Respir J (2008) 1.11
Prevalence of asthma symptoms among adolescents in the Wellington region, by area and ethnicity. N Z Med J (1993) 1.10
Time-related factors as potential confounders and effect modifiers in studies based on an occupational cohort. Scand J Work Environ Health (1986) 1.10
Mortality in New Zealand workers exposed to phenoxy herbicides and dioxins. Occup Environ Med (2005) 1.10
Short- and medium-term results of totally laparoscopic resection for colorectal liver metastases. Br J Surg (2010) 1.09
Reduced selenium in asthmatic subjects in New Zealand. Thorax (1990) 1.09
Detection and morphology of thymic remnants after video-assisted thoracoscopic extended thymectomy (VATET) in patients with myasthenia gravis. Int Surg (1996) 1.09
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Bone metabolism in type 2 diabetes mellitus. Acta Diabetol (1999) 1.08
Congenital defects and miscarriages among New Zealand 2, 4, 5-T sprayers. Arch Environ Health (1982) 1.07
Differential activation by Ca2+, ATP and caffeine of cardiac and skeletal muscle ryanodine receptors after block by Mg2+. J Membr Biol (2002) 1.07
Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy (2000) 1.07
Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia (1981) 1.07
Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol (2005) 1.06
Trends in pancreatic cancer mortality in Europe, 1955-1989. Int J Cancer (1994) 1.06
Clinical assessment of dysphagia in early phases of Parkinson's disease. Neurol Sci (2002) 1.05
The magnitude of the effect of smaller family sizes on the increase in the prevalence of asthma and hay fever in the United Kingdom and New Zealand. J Allergy Clin Immunol (1999) 1.05